Clinical Trial Update: Repurposing Valsartan May Protect Against Pulmonary Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is exploring repurposing valsartan to protect against pulmonary arterial hypertension and related right-heart conditions; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Vascular Disorder
• Right Heart Failure
• Right Ventricular Dysfunction

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: University of Washington | Conditions: Pulmonary Arterial Hypertension, Right Heart Failure | Phase 2 | Status: RECRUITING